Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-24 @ 11:44 PM
NCT ID: NCT05956951
Eligibility Criteria: Inclusion Criteria: Early-course schizophrenia (EC-SCZ): 1. ages 18-40 years 2. current DSM-IV defined diagnosis of schizophrenia, schizophreniform or schizoaffective disorder, not drug-induced, with no previously reported psychotic episode 3. duration of ≤5 years from beginning of psychosis, defined by report of symptoms and/or history of treatment according to clinical guidelines employed in our University of Pittsburgh Medical Center (UPMC) psychoses clinics in Pittsburgh 4. lifetime exposure to antipsychotic medications ≤5 years Healthy controls (HC): 1. ages 18-40 years 2. no lifetime history of psychiatric disorders 3. no first-degree family history of schizophrenia spectrum disorder or mood disorder with psychotic features. Exclusion Criteria: General exclusion criteria: 1. DSM-IV intellectual disability 2. significant head injury 3. medical illness affecting brain function or structure 4. pregnancy or postpartum (\<6 weeks after delivery or miscarriage) 5. significant neurological disorder (e.g. seizure disorder) 6. inability to provide informed consent 7. current or past co-morbidity for alcohol or psychoactive substance dependence 8. substance abuse other than cannabis and/or alcohol within the past one year For EC-SCZ: a) a psychotic illness with a temporal relation to substance use or head injury For healthy controls (HC): 1. difficult falling and/or staying asleep for more than half the nights of a week, on average 2. diagnosis of sleep apnea or restless leg syndrome 3. sleeping less than 5 hours or more than 10 hours daily, on average
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 40 Years
Study: NCT05956951
Study Brief:
Protocol Section: NCT05956951